结论应用等渗对比剂可降低对比剂肾病的发生率。
Conclusion Using iso-osmolar contrast media may prevent from contrast-induced nephropathy.
该研究是迄今最大的一项在高危人群中比较等渗对比剂和低渗对比剂的肾脏耐受性的前瞻、随机、双盲、平行试验。
One is for future studies of kidney injury prevention and clinical trial design. Future studies will want to look at long term adverse events.
应用推荐